WEGOVY 2.4 MG/0.75 ML PEN

semaglutide
$435.4330per ML

Strength

2.4 mg/.75mL

Manufacturer

Novo Nordisk

NDC

00169452414

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

SEMAGLUTIDE

Approval Type

New Drug (NDA)

FDA Application

NDA215256

On Market Since

6/5/2021

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

+0.1%

1Y

+0.3%

3Y

+0.9%

5Y

N/A

All

+0.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.